recombinant human galectin Search Results


recombinant human gal 9 protein  (R&D Systems)
94
R&D Systems recombinant human gal 9 protein
Recombinant Human Gal 9 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human gal 9 protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human gal 9 protein - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
recombinant galectin  (R&D Systems)
93
R&D Systems recombinant galectin
Recombinant Galectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant galectin/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant galectin - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
human gal 3 protein  (R&D Systems)
93
R&D Systems human gal 3 protein
Human Gal 3 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gal 3 protein/product/R&D Systems
Average 93 stars, based on 1 article reviews
human gal 3 protein - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
recombinant human galectin 8  (R&D Systems)
91
R&D Systems recombinant human galectin 8
Recombinant Human Galectin 8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human galectin 8/product/R&D Systems
Average 91 stars, based on 1 article reviews
recombinant human galectin 8 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier
recombinant human galectin 3  (R&D Systems)
94
R&D Systems recombinant human galectin 3
Recombinant Human Galectin 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human galectin 3/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human galectin 3 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
recombinant human gal  (R&D Systems)
92
R&D Systems recombinant human gal
Recombinant Human Gal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human gal/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant human gal - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
recombinant human galectin  (R&D Systems)
92
R&D Systems recombinant human galectin
Recombinant Human Galectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human galectin/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant human galectin - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
recombinant protein lgals3bp  (R&D Systems)
93
R&D Systems recombinant protein lgals3bp
Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, <t>LGALS3BP</t> / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.
Recombinant Protein Lgals3bp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant protein lgals3bp/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant protein lgals3bp - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
n terminal his tag recombinant human clc p gal10  (Novus Biologicals)
92
Novus Biologicals n terminal his tag recombinant human clc p gal10
Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, <t>LGALS3BP</t> / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.
N Terminal His Tag Recombinant Human Clc P Gal10, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n terminal his tag recombinant human clc p gal10/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
n terminal his tag recombinant human clc p gal10 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
human gal 8  (R&D Systems)
91
R&D Systems human gal 8
Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, <t>LGALS3BP</t> / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.
Human Gal 8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gal 8/product/R&D Systems
Average 91 stars, based on 1 article reviews
human gal 8 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier
recombinant galectin binding  (R&D Systems)
94
R&D Systems recombinant galectin binding
Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, <t>LGALS3BP</t> / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.
Recombinant Galectin Binding, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant galectin binding/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant galectin binding - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
human gal 2  (R&D Systems)
91
R&D Systems human gal 2
Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, <t>LGALS3BP</t> / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.
Human Gal 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gal 2/product/R&D Systems
Average 91 stars, based on 1 article reviews
human gal 2 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

Image Search Results


Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, LGALS3BP / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Article Title: Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages.

doi: 10.1016/j.matbio.2024.06.001

Figure Lengend Snippet: Fig. 4. (A) Visualization of the RNAseq expression data and (B) LC-MS-based secretome data of IGFBP1 / IGFBP1, LGALS3BP / LGALS3BP, LYVE1 / LYVE1, and PTX3 / PTX3 in CAF populations compared to nFB, and (C) qRT-PCR-based validation of IGFBP1, LGALS3BP, LYVE1, and PTX3 expression in nFB and CAF (SE-CAF = 6, EC- CAF = 3, TER-CAF = 3, nFB = 5). SD is based on biological replicates. GAPDH and ACTB were used as housekeepers and for data normalization. (D) Measurement of LGALS3BP secretion in nFB and CAF via ELISA, dots indicate the biological replicates (n = 3 / subgroup). (E) Cell proliferation assay of TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d. SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). (F) qRT-PCR analysis of expression of cisplatin resistance-associated factors in TCam-2 (SE) and 2102EP, NCCIT, NT2/D1 (EC) treated daily with recombinant proteins (LGALS3BP, LYVE1, IGFBP1; 10 - 100 ng / mL) over 10 d SE-related SD is based on technical triplicates; EC-related SD is based on biological triplicates (each in technical triplicates). GAPDH and ACTB were used as housekeepers and for data normalization. Dashed lines indicate the threshold of a FC > 1.5 / < -1.5.

Article Snippet: For TCam-2, 1300 cells and for EC cells, 2650 cells per well of a 24- well plate were seeded, treated daily with recombinant protein LGALS3BP (2226-GAB), LYVE1 (2089-LY) or IGFBP1 (871-B1–025) (all R&D Systems) and counted in technical triplicates over 10 d using a Neubauer counting chamber.

Techniques: Expressing, Liquid Chromatography with Mass Spectroscopy, Quantitative RT-PCR, Biomarker Discovery, Enzyme-linked Immunosorbent Assay, Proliferation Assay, Recombinant

Fig. 5. (A) Experimental setup of this analysis. THP-1 monocytes were differentiated into M0 macrophages by PMA. Afterwards, macrophages were cultivated in CM or treated with recombinant proteins, subsequently expression of M1LPS/IFNγ and M2IL4/IL13 marker genes was analyzed by qRT-PCR. (B) Heatmap of gene expression levels (FC to control) of THP-1-M0-macrophages cultivated in nFB, SE- / EC-CAF CM (n = 3 / each) or (C) treated with recombinant proteins (LGALS3BP, LYVE1, PTX3; 10 - 100 ng / mL) over 72 h. GAPDH and ACTB were used as housekeepers and for data normalization. Average overall expression intensities were used for clustering. Arrows highlight genes used for futher analysis.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Article Title: Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages.

doi: 10.1016/j.matbio.2024.06.001

Figure Lengend Snippet: Fig. 5. (A) Experimental setup of this analysis. THP-1 monocytes were differentiated into M0 macrophages by PMA. Afterwards, macrophages were cultivated in CM or treated with recombinant proteins, subsequently expression of M1LPS/IFNγ and M2IL4/IL13 marker genes was analyzed by qRT-PCR. (B) Heatmap of gene expression levels (FC to control) of THP-1-M0-macrophages cultivated in nFB, SE- / EC-CAF CM (n = 3 / each) or (C) treated with recombinant proteins (LGALS3BP, LYVE1, PTX3; 10 - 100 ng / mL) over 72 h. GAPDH and ACTB were used as housekeepers and for data normalization. Average overall expression intensities were used for clustering. Arrows highlight genes used for futher analysis.

Article Snippet: For TCam-2, 1300 cells and for EC cells, 2650 cells per well of a 24- well plate were seeded, treated daily with recombinant protein LGALS3BP (2226-GAB), LYVE1 (2089-LY) or IGFBP1 (871-B1–025) (all R&D Systems) and counted in technical triplicates over 10 d using a Neubauer counting chamber.

Techniques: Recombinant, Expressing, Marker, Quantitative RT-PCR, Gene Expression, Control